Comparison of Antimicrobial Resistance of Campylobacter jejuni and Campylobacter coli Isolated from Humans and Chicken Carcasses in Poland

Campylobacter-associated gastroenteritis remains an important cause of morbidity worldwide, and some evidence suggests that poultry is an important source of this foodborne infection in humans. This study was conducted to analyze the prevalence and genetic background of resistance of 149 Campylobacter jejuni and 54 Campylobacter coli strains isolated from broiler chicken carcasses and from stool samples of infected children in Poland from 2003 through 2005. Nearly all isolates were susceptible to macrolides and aminoglycosides. The highest resistance in both human and chicken strains was observed for ciprofloxacin (more than 40%), followed by ampicillin (13 to 21%), and tetracycline (8 to 29%). Resistance to ampicillin and tetracycline rose significantly between 2003 and 2005. Slight differences in resistance between human and chicken isolates indicate that although chicken meat is not the only source of Campylobacter infection in our population, it can be involved in the transmission of drug-resistant Campylobacter strains to humans.

[1]  N. Stern,et al.  Counts of Campylobacter spp. on U.S. broiler carcasses. , 2006, Journal of food protection.

[2]  D. Korsak,et al.  Prevalence of potential virulence markers in Polish Campylobacter jejuni and Campylobacter coli isolates obtained from hospitalized children and from chicken carcasses. , 2005, Journal of medical microbiology.

[3]  A. Fernández-Astorga,et al.  PCR-Restriction Fragment Length Polymorphism Assay for Detection of gyrA Mutations Associated with Fluoroquinolone Resistance in Campylobacter coli , 2004, Antimicrobial Agents and Chemotherapy.

[4]  S. Connell,et al.  Incidence of Antibiotic Resistance in Campylobacter jejuni Isolated in Alberta, Canada, from 1999 to 2002, with Special Reference to tet(O)-Mediated Tetracycline Resistance , 2004, Antimicrobial Agents and Chemotherapy.

[5]  L. Piddock,et al.  Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. , 2004, The Journal of antimicrobial chemotherapy.

[6]  F. Aarestrup,et al.  Quinolone-resistant Campylobacter Infections: Risk Factors and Clinical Consequences , 2004, Emerging infectious diseases.

[7]  H. Lindmark,et al.  Genetic Characterization and Antibiotic Resistance of Campylobacter jejuni Isolated from Meats, Water, and Humans in Sweden , 2004, Journal of Clinical Microbiology.

[8]  I. Wilson.  Antibiotic resistance of Campylobacter in raw retail chickens and imported chicken portions , 2003, Epidemiology and Infection.

[9]  H. Hahn,et al.  Antimicrobial Resistance in Campylobacter jejuni and Campylobacter coli Strains Isolated in 1991 and 2001-2002 from Poultry and Humans in Berlin, Germany , 2003, Antimicrobial Agents and Chemotherapy.

[10]  L. Piddock,et al.  Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals. , 2003, The Journal of antimicrobial chemotherapy.

[11]  F. Mégraud,et al.  PCR-Restriction Fragment Length Polymorphism Analysis for Detection of Point Mutations Associated with Macrolide Resistance in Campylobacter spp , 2003, Antimicrobial Agents and Chemotherapy.

[12]  R. Isokpehi,et al.  Human Campylobacteriosis in Developing Countries1 , 2002, Emerging infectious diseases.

[13]  F. Aarestrup,et al.  Antimicrobial resistance of thermophilic Campylobacter. , 2001, Veterinary research.

[14]  B. Allos.  Campylobacter jejuni Infections: update on emerging issues and trends. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  F. Aarestrup,et al.  Macrolide Resistance in Campylobacter coli of Animal Origin in Denmark , 2001, Antimicrobial Agents and Chemotherapy.

[16]  A. Hilton,et al.  The kitchen dishcloth as a source of and vehicle for foodborne pathogens in a domestic setting , 2000 .

[17]  B. Swaminathan,et al.  Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR. , 2000, FEMS microbiology letters.

[18]  F. Baquero,et al.  Antibiotic Resistance in CampylobacterStrains Isolated from Animals, Foods, and Humans in Spain in 1997–1998 , 2000, Antimicrobial Agents and Chemotherapy.

[19]  G. Zirnstein,et al.  Ciprofloxacin Resistance in Campylobacter jejuniIsolates: Detection of gyrA Resistance Mutations by Mismatch Amplification Mutation Assay PCR and DNA Sequence Analysis , 1999, Journal of Clinical Microbiology.

[20]  M. Blaser,et al.  Epidemiologic and clinical features of Campylobacter jejuni infections. , 1997, The Journal of infectious diseases.

[21]  W. Rozenbaum,et al.  Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group. , 1997, The Journal of infectious diseases.

[22]  L. Piddock,et al.  Quinolone resistance and Campylobacter spp. , 1995, The Journal of antimicrobial chemotherapy.

[23]  N. Stern,et al.  Comparison of Three Methods for Recovery of Campylobacter spp. from Broiler Carcasses. , 1992, Journal of food protection.

[24]  T. Gootz,et al.  Characterization of high-level quinolone resistance in Campylobacter jejuni , 1991, Antimicrobial Agents and Chemotherapy.

[25]  N. Weiss,et al.  The role of poultry and meats in the etiology of Campylobacter jejuni/coli enteritis. , 1986, American journal of public health.

[26]  F. Aarestrup,et al.  Diagnosis and Antimicrobial Susceptibility of Campylobacter species , 2008 .

[27]  A. Hoszowski,et al.  Wystepowanie i antybiotykoopornosc paleczek Salmonella w Polsce , 2005 .

[28]  F. Aarestrup,et al.  Quinolone-resistant Campylobacter Infections in Denmark: Risk Factors and Clinical Consequences 1 , 2004 .

[29]  C. Dalton,et al.  Antibiotic resistance in Campylobacter jejuni isolated from humans in the Hunter Region, New South Wales. , 2003, Communicable diseases intelligence quarterly report.

[30]  L. Piddock,et al.  Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. , 2003, The Journal of antimicrobial chemotherapy.

[31]  C. Soussy,et al.  Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. , 2001, Microbial drug resistance.

[32]  F. Aarestrup,et al.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. , 2001, Emerging infectious diseases.

[33]  E. Gornowicz,et al.  Antybiotykowe stymulatory wzrostu w produkcji drobiu , 1999 .

[34]  S. Altekruse,et al.  Campylobacter jejuni--an emerging foodborne pathogen. , 1999, Emerging infectious diseases.

[35]  P. L. Griffiths,et al.  Sources and survival of campylobacters: relevance to enteritis and the food industry. , 1991, Society for Applied Bacteriology symposium series.